HPV vaccination for transgender people
Trans women (people assigned male at birth) are eligible in the same way as MSM if their risk of getting HPV is similar to the risk of MSM who are eligible for the vaccine. Trans men (people assigned female at birth) are eligible if they have sex with other men and are aged 45 or under. If trans men have previously completed a course of HPV vaccines as part of the girls HPV vaccine programme, no more doses are needed.
How is the HPV vaccine given?
The HPV vaccine is currently given into the upper arm.
How long does the HPV vaccine protect for?
Studies have already shown that the vaccine protects against HPV infection for at least 10 years, although experts expect protection to last for much longer. HPV vaccine does not protect against all types of HPV that can cause cervical cancer, so it's important that all girls who receive the HPV vaccine also have regular cervical screening once they reach the age of 25.
In Australia and the UK boys and girls in school receive Gardasil 9 which protects against nine HPV types which cause around 90% of cervical cancers in women, 95% of all HPV-related cancers in men and 90% of genital warts in both men and women. The research which resulted in the HPV vaccine was originally developed at University of Queensland in Brisbane, Queensland by Professor Ian Frazer and his late colleague, Dr.Jian Zhou. Professor Ian Fraser was awarded Australian of the Year in 2006 for the invention. More than 270 million doses of HPV vaccines have been administered worldwide as of May 2017 and the HPV vaccine has proven to be extremely safe and effective.